BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38506839)

  • 1. Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.
    Gibbons CH; Levine T; Adler C; Bellaire B; Wang N; Stohl J; Agarwal P; Aldridge GM; Barboi A; Evidente VGH; Galasko D; Geschwind MD; Gonzalez-Duarte A; Gil R; Gudesblatt M; Isaacson SH; Kaufmann H; Khemani P; Kumar R; Lamotte G; Liu AJ; McFarland NR; Miglis M; Reynolds A; Sahagian GA; Saint-Hillaire MH; Schwartzbard JB; Singer W; Soileau MJ; Vernino S; Yerstein O; Freeman R
    JAMA; 2024 Apr; 331(15):1298-1306. PubMed ID: 38506839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
    Giannoccaro MP; Donadio V; Giannini G; Devigili G; Rizzo G; Incensi A; Cason E; Calandra-Buonaura G; Eleopra R; Cortelli P; Liguori R
    Parkinsonism Relat Disord; 2020 Dec; 81():48-53. PubMed ID: 33049589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease.
    Gibbons C; Wang N; Rajan S; Kern D; Palma JA; Kaufmann H; Freeman R
    Neurology; 2023 Apr; 100(15):e1529-e1539. PubMed ID: 36657992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synuclein-One study: skin biopsy detection of phosphorylated α-synuclein for diagnosis of synucleinopathies.
    Gibbons CH; Freeman R; Bellaire B; Adler CH; Moore D; Levine T
    Biomark Med; 2022 May; 16(7):499-509. PubMed ID: 35272481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy.
    Donadio V; Incensi A; Rizzo G; Westermark GT; Devigili G; De Micco R; Tessitore A; Nyholm D; Parisini S; Nyman D; Tedeschi G; Eleopra R; Ingelsson M; Liguori R
    Brain; 2023 Mar; 146(3):1065-1074. PubMed ID: 35552610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies.
    Leys F; Wenning GK; Fanciulli A
    Neurol Sci; 2022 Jan; 43(1):187-198. PubMed ID: 34817726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin α-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study.
    Donadio V; Incensi A; El-Agnaf O; Rizzo G; Vaikath N; Del Sorbo F; Scaglione C; Capellari S; Elia A; Stanzani Maserati M; Pantieri R; Liguori R
    Sci Rep; 2018 Sep; 8(1):14246. PubMed ID: 30250046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting phenoconversion in pure autonomic failure.
    Coon EA; Mandrekar JN; Berini SE; Benarroch EE; Sandroni P; Low PA; Singer W
    Neurology; 2020 Aug; 95(7):e889-e897. PubMed ID: 32546656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview on pure autonomic failure.
    Pavy-Le Traon A; Foubert-Samier A; Fabbri M
    Rev Neurol (Paris); 2024; 180(1-2):94-100. PubMed ID: 38129276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies.
    Rossi M; Candelise N; Baiardi S; Capellari S; Giannini G; Orrù CD; Antelmi E; Mammana A; Hughson AG; Calandra-Buonaura G; Ladogana A; Plazzi G; Cortelli P; Caughey B; Parchi P
    Acta Neuropathol; 2020 Jul; 140(1):49-62. PubMed ID: 32342188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.
    Foulds PG; Yokota O; Thurston A; Davidson Y; Ahmed Z; Holton J; Thompson JC; Akiyama H; Arai T; Hasegawa M; Gerhard A; Allsop D; Mann DM
    Neurobiol Dis; 2012 Jan; 45(1):188-95. PubMed ID: 21856424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy.
    Kao AW; Racine CA; Quitania LC; Kramer JH; Christine CW; Miller BL
    Alzheimer Dis Assoc Disord; 2009; 23(4):365-70. PubMed ID: 19935145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies - a mini review.
    Singer W
    Clin Auton Res; 2022 Aug; 32(4):291-297. PubMed ID: 35895157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autonomic Dysfunction and Skin Biopsy in Dementia with Lewy Bodies].
    Orimo S
    Brain Nerve; 2018 Aug; 70(8):915-927. PubMed ID: 30082501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward.
    Bellomo G; De Luca CMG; Paoletti FP; Gaetani L; Moda F; Parnetti L
    Neurology; 2022 Aug; 99(5):195-205. PubMed ID: 35914941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
    Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
    Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylated α-Synuclein Deposits in Cutaneous Nerves of Early Parkinsonism.
    Nolano M; Caporaso G; Manganelli F; Stancanelli A; Borreca I; Mozzillo S; Tozza S; Dubbioso R; Iodice R; Vitale F; Koay S; Vichayanrat E; da Silva FV; Santoro L; Iodice V; Provitera V
    J Parkinsons Dis; 2022; 12(8):2453-2468. PubMed ID: 36373295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure.
    Singer W; Schmeichel AM; Shahnawaz M; Schmelzer JD; Sletten DM; Gehrking TL; Gehrking JA; Olson AD; Suarez MD; Misra PP; Soto C; Low PA
    Ann Neurol; 2021 Jun; 89(6):1212-1220. PubMed ID: 33881777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies.
    Goldstein DS; Isonaka R; Lamotte G; Kaufmann H
    Clin Auton Res; 2021 Dec; 31(6):677-684. PubMed ID: 34669076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy.
    Mori F; Piao YS; Hayashi S; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
    J Neuropathol Exp Neurol; 2003 Aug; 62(8):812-9. PubMed ID: 14503637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.